HUE061945T2 - Heteroarilfenoxi-benzamid kappa opioid ligandumok - Google Patents

Heteroarilfenoxi-benzamid kappa opioid ligandumok

Info

Publication number
HUE061945T2
HUE061945T2 HUE17818281A HUE17818281A HUE061945T2 HU E061945 T2 HUE061945 T2 HU E061945T2 HU E17818281 A HUE17818281 A HU E17818281A HU E17818281 A HUE17818281 A HU E17818281A HU E061945 T2 HUE061945 T2 HU E061945T2
Authority
HU
Hungary
Prior art keywords
heteroarylphenoxy
benzamide
kappa opioid
opioid ligands
ligands
Prior art date
Application number
HUE17818281A
Other languages
English (en)
Inventor
Kapildev Kashmirilal Arora
Michael Aaron Brodney
Matthew Francis Dunn
Michael Eric Green
Natasha Mariam Kablaoui
Gregory Wayne Kauffman
Scot Richard Mente
Justin Ian Montgomery
Danica Antonia Rankic
Bruce Nelsen Rogers
Patrick Robert Verhoest
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of HUE061945T2 publication Critical patent/HUE061945T2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18One oxygen or sulfur atom
    • C07D231/20One oxygen atom attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
HUE17818281A 2016-11-28 2017-11-27 Heteroarilfenoxi-benzamid kappa opioid ligandumok HUE061945T2 (hu)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662426980P 2016-11-28 2016-11-28
US201762576435P 2017-10-24 2017-10-24
US201762585016P 2017-11-13 2017-11-13

Publications (1)

Publication Number Publication Date
HUE061945T2 true HUE061945T2 (hu) 2023-09-28

Family

ID=60782279

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE17818281A HUE061945T2 (hu) 2016-11-28 2017-11-27 Heteroarilfenoxi-benzamid kappa opioid ligandumok

Country Status (19)

Country Link
US (1) US10316021B2 (hu)
EP (1) EP3544972B8 (hu)
JP (1) JP7051853B2 (hu)
CN (1) CN110234638B (hu)
AU (1) AU2017365123B2 (hu)
CA (1) CA3045242A1 (hu)
DK (1) DK3544972T3 (hu)
ES (1) ES2947293T3 (hu)
FI (1) FI3544972T3 (hu)
HR (1) HRP20230518T1 (hu)
HU (1) HUE061945T2 (hu)
IL (1) IL266962B (hu)
MX (1) MX2019006220A (hu)
PH (1) PH12019501172A1 (hu)
PL (1) PL3544972T3 (hu)
PT (1) PT3544972T (hu)
RS (1) RS64258B1 (hu)
TW (1) TWI720272B (hu)
WO (1) WO2018096510A1 (hu)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018154118A2 (en) * 2017-02-24 2018-08-30 Reinmueller Viktoria Novel aromatic compounds
EP3585485A2 (en) 2017-02-24 2020-01-01 Xeniopro GmbH Aromatic compounds which enhance notch signaling, for use in therapy
US11266627B1 (en) 2021-05-04 2022-03-08 Janssen Pharmaceuticals, Inc. Compositions and methods for the treatment of depression
CN111233768B (zh) * 2020-03-18 2021-08-03 徐州圣元化工有限公司 一种3-(二氟甲基)-1-甲基-1h-吡唑-4-羧酸乙酯的制备方法
CN114641485A (zh) * 2020-04-05 2022-06-17 辉瑞大药厂 用于治疗covid-19的化合物和方法
US20220370409A1 (en) 2021-05-04 2022-11-24 Janssen Pharmaceuticals, Inc. Compositions And Methods For The Treatment Of Depression
WO2023170547A1 (en) * 2022-03-07 2023-09-14 Janssen Pharmaceuticals, Inc. Pure forms of crystalline aticaprant
US11998524B2 (en) 2022-03-07 2024-06-04 Janssen Pharmaceuticals, Inc. Forms of aticaprant
WO2024079733A1 (en) * 2022-10-12 2024-04-18 Adama Makhteshim Ltd. Process for the preparation of aminopyridazine derivatives

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0166088B1 (ko) 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
US5376645A (en) 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
GB9518953D0 (en) 1995-09-15 1995-11-15 Pfizer Ltd Pharmaceutical formulations
WO2000035296A1 (en) 1996-11-27 2000-06-22 Wm. Wrigley Jr. Company Improved release of medicament active agents from a chewing gum coating
GB9711643D0 (en) 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
JP2000159747A (ja) * 1998-09-21 2000-06-13 Takeda Chem Ind Ltd 新規チオ―ル誘導体、その製造法および用途
EP1132379A4 (en) 1998-09-21 2005-02-16 Takeda Pharmaceutical THIOL DERIVATIVES, METHOD FOR THEIR PREPARATION AND THEIR USE
IT1303737B1 (it) 1998-11-11 2001-02-23 Smithkline Beecham Spa Derivati fenilpiperidinici procedimento per la loro preparazione eloro uso come ligandi del recettore orl-1.
DK2208727T3 (da) 2002-09-19 2012-09-17 Lilly Co Eli Diarylethere som opioidreceptorantagonister
US7365209B2 (en) 2003-02-11 2008-04-29 Pharmacopeia, Inc. Nitrogen heterocycle biaryls for osteoporosis and other diseases
US7396943B2 (en) 2003-03-07 2008-07-08 Eli Lilly And Company Opioid receptor antagonists
NZ542304A (en) 2003-03-14 2009-07-31 Ono Pharmaceutical Co Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient
EP1773797A2 (en) 2004-08-06 2007-04-18 Otsuka Pharmaceutical Co., Ltd. Aromatic compounds
EP1849835B1 (en) 2005-02-18 2017-08-30 Nippon Soda Co., Ltd. Organic-inorganic composite body
CA2644368A1 (en) 2006-03-10 2007-09-20 Ono Pharmaceutical Co., Ltd. Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient
RS51211B (sr) 2006-04-04 2010-12-31 Emodis Gmbh. Primena formulacija koje sadrže kapa-opioid receptor-agoniste za tretman disocijativnih poremećaja
PE20091317A1 (es) 2008-01-22 2009-09-03 Lilly Co Eli Antagonista del receptor opioide selectivo kappa
WO2009102893A2 (en) 2008-02-14 2009-08-20 Amira Pharmaceuticals, Inc. CYCLIC DIARYL ETHER COMPOUNDS AS ANTAGONISTS OF PROSTAGLANDIN D2 receptors
CR11559A (es) 2008-03-25 2010-10-20 Lilly Co Eli Antagonista del receptor opioide selectivo kappa
US8048895B2 (en) 2008-04-18 2011-11-01 Research Triangle Institute Kappa opioid receptor ligands
CN102083800A (zh) 2008-06-27 2011-06-01 阿维拉制药公司 杂芳基化合物和其用途
EP2379524A1 (en) 2008-12-18 2011-10-26 Boehringer Ingelheim International GmbH Serotonin 5-ht2b receptor inhibitors
HN2010001319A (es) 2009-01-26 2013-01-15 Lilly Co Eli Antagonista del receptor opioide selectivo kappa
WO2013059648A1 (en) 2011-10-21 2013-04-25 Neurotherapeutics Pharma, Inc. 2,3,5 trisubstituted aryl and heteroaryl amino derivatives, compositions, and methods of use
CA2886904A1 (en) 2012-10-02 2014-04-10 Cyril Montagne Pyrrolidines
WO2015109080A1 (en) 2014-01-15 2015-07-23 Research Triangle Institute Kappa-opioid receptor selective opioid receptor antagonists
US10118896B2 (en) 2014-11-26 2018-11-06 University Of Kansas Antagonists of the kappa opioid receptor

Also Published As

Publication number Publication date
PL3544972T3 (pl) 2023-07-24
AU2017365123A1 (en) 2019-07-11
TW201831460A (zh) 2018-09-01
FI3544972T3 (fi) 2023-06-02
TWI720272B (zh) 2021-03-01
IL266962A (en) 2019-07-31
DK3544972T3 (da) 2023-05-30
WO2018096510A1 (en) 2018-05-31
EP3544972A1 (en) 2019-10-02
IL266962B (en) 2022-02-01
CA3045242A1 (en) 2018-05-31
PT3544972T (pt) 2023-06-20
ES2947293T3 (es) 2023-08-04
RS64258B1 (sr) 2023-07-31
HRP20230518T1 (hr) 2023-08-04
AU2017365123B2 (en) 2022-02-17
US20180148432A1 (en) 2018-05-31
CN110234638A (zh) 2019-09-13
JP7051853B2 (ja) 2022-04-11
US10316021B2 (en) 2019-06-11
CN110234638B (zh) 2022-10-21
EP3544972B1 (en) 2023-04-26
JP2019535799A (ja) 2019-12-12
MX2019006220A (es) 2019-10-07
EP3544972B8 (en) 2023-06-07
PH12019501172A1 (en) 2019-12-11

Similar Documents

Publication Publication Date Title
PL3544972T3 (pl) Heteroarylofenoksybenzamidowe ligandy opioidowe kappa
HUE057538T2 (hu) Folyékony huzal
GB201513850D0 (en) Coordinate positioning machine
HK1258960A1 (zh) 2環性雜環化合物
GB2547540B (en) Strainers
GB201522437D0 (en) Tethered ligands
GB2571867B (en) Wire strainers
GB201514584D0 (en) A gasket
HK1255842A1 (zh) 床墊
GB201406237D0 (en) A securable furniture arrangement
GB201610705D0 (en) A mattress
GB201509847D0 (en) Anti-dandruff agents
GB201509848D0 (en) Anti-dandruff Agents
GB201615838D0 (en) Strainers
GB201509849D0 (en) Anti-dandruff agents
RS63518B1 (sr) Nova zaptivna struktura
ZA201802212B (en) A concealment cover
PL3551025T3 (pl) Zmywarka do naczyń
PL3515274T3 (pl) Zmywarka do naczyń
GB201620135D0 (en) Concept nine
GB2543370B (en) A gasket arrangement
GB2548068B (en) A mattress
AU201614145S (en) A sofa
AU201614884S (en) Tub
GB201614617D0 (en) Ooctye Needles